logo

Gujarat Kidney and Super Speciality IPO

₹13,824/128 shares

Minimum Investment

IPO Details

Open Date

22 Dec 25

Close Date

24 Dec 25

Minimum Investment

13,824

Lot Size

128

Price Range

108 to ₹114

Listing Exchange

NSE, BSE

Issue Size

250.80 Cr

Listing Date

30 Dec 25

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Gujarat Kidney and Super Speciality IPO Timeline

Bidding Start

22 Dec 25

Bidding Ends

24 Dec 25

Allotment Finalisation

26 Dec 25

Refund Initiation

29 Dec 25

Demat Transfer

29 Dec 25

Listing

30 Dec 25

Gujarat Kidney & Super Speciality Limited IPO

Incorporated in 2019, Gujarat Kidney & Super Speciality Limited operates a chain of multispeciality hospitals across Gujarat. The company focuses on secondary and tertiary healthcare services, with a strong presence in renal sciences and urology. It manages seven hospitals and four pharmacies with a total operational bed capacity of 340 beds. Backed by experienced medical professionals, the company delivers specialised surgical and critical care services while maintaining consistent operational growth across locations.

Gujarat Kidney & Super Speciality Limited IPO Overview

Gujarat Kidney & Super Speciality Limited IPO is a bookbuilding issue of ₹250.80 crore, comprising entirely a fresh issue of 2.20 crore equity shares. The IPO opens for subscription on 22 December 2025 and closes on 24 December 2025. The price band is fixed at ₹108 to ₹114 per share with a lot size of 128 shares. The issue will list on BSE and NSE, with Nirbhay Capital Services Pvt. Ltd. acting as the book running lead manager and MUFG Intime India Pvt. Ltd. as the registrar.

Gujarat Kidney & Super Speciality Limited IPO Details

Particulars Details
IPO Date 22 December 2025 to 24 December 2025
Listing Date 30 December 2025
Face Value ₹2 per share
Issue Price Band ₹108 to ₹114 per share
Lot Size 128 Shares
Total Issue Size 2,20,00,000 shares (₹250.80 Cr)
Fresh Issue 2,20,00,000 shares (₹250.80 Cr)
Offer for Sale NA
Issue Type Bookbuilding IPO
Listing At BSE, NSE
Share Holding Pre Issue 5,68,43,250 shares
Share Holding Post Issue 7,88,43,250 shares

Gujarat Kidney & Super Speciality Limited IPO Reservation

Investor Category Shares Offered
QIB Not less than 75% of the Net Issue
Retail Not more than 10% of the Net Issue
NII (HNI) Not more than 15% of the Net Issue

Gujarat Kidney & Super Speciality Limited IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 128 ₹14,592
Retail (Max) 13 1,664 ₹1,89,696
S-HNI (Min) 14 1,792 ₹2,04,288
B-HNI (Min) 69 8,832 ₹10,06,848

Gujarat Kidney & Super Speciality Limited IPO Promoter Holding

Shareholding Status Percentage
Pre-Issue 99.10%
Post-Issue 71.45%

Gujarat Kidney & Super Speciality Limited IPO Valuation Overview

KPI Value
Earnings Per Share (EPS) ₹1.85
Price/Earnings (P/E) Ratio 61.62x
Return on Net Worth (RoNW) 36.61%
Net Asset Value (NAV) ₹5.04
Return on Equity 36.61%
Return on Capital Employed (ROCE) 37.65%
EBITDA Margin 41.12%
PAT Margin 23.61%
Debt to Equity Ratio 0.15

Objectives of the Proceeds

  • Acquisition of Parekhs Hospital, Ahmedabad – ₹77.00 Cr
  • Part-payment for Ashwini Medical Centre acquisition – ₹12.40 Cr
  • Capital expenditure for new Vadodara hospital – ₹30.10 Cr
  • Purchase of advanced robotic medical equipment – ₹6.83 Cr
  • Repayment or prepayment of secured borrowings – ₹1.20 Cr
  • Inorganic growth initiatives and general corporate purposes

Key Financials (in ₹ crore)

Particulars 31 Mar 2025 31 Mar 2024 31 Mar 2023
Assets 55.34 20.53 3.87
Revenue 40.40 5.48 0.00
Profit After Tax 9.50 1.71 -0.01
Reserves and Surplus 14.57 10.60 0.17
Total Borrowings 3.88 1.94 NA

SWOT Analysis of Gujarat Kidney and Super Speciality IPO

Strength and Opportunities

  • Experienced medical promoters with renal specialisation
  • Strong presence across Gujarat healthcare markets
  • Asset-light expansion model supports scalability
  • Growing demand for tertiary healthcare services

Risks and Threats

  • High dependence on specialist doctors
  • Regulatory risks in healthcare operations
  • Rising operational and equipment costs
  • Competitive pressure from listed hospital chains

Explore IPO Opportunities

Explore our comprehensive IPO pages to stay updated on the latest trends and insights.

About Gujarat Kidney & Super Speciality Limited

Gujarat Kidney & Super Speciality IPO Strengths

  • Promoters and management team possess extensive experience and clinical expertise.
  • Established multispeciality hospital network across key healthcare locations in Gujarat.
  • Strong focus on renal sciences with specialised tertiary care capabilities.
  • Asset-light expansion model supporting scalable and capital-efficient growth.
  • Ability to attract and retain experienced doctors and skilled healthcare professionals.
  • Consistent financial growth supported by increasing patient footfalls and service mix.
Company Name EPS (Basic) EPS (Diluted) NAV (per share) (₹) P/E (x) RoNW (%) P/BV Ratio
Gujarat Kidney & Super Speciality Limited 1.85 1.85 5.04 NA 36.61 NA
Peer Group
Yatharth Hospital & Trauma Care Services Limited 14.72 14.83 88.05 55.84 8.13 9.34
GPT Healthcare Limited 6.08 12.26 40.71 24.51 20.14 3.73
KMC Speciality Hospitals (India) Ltd 1.31 9.25 23.16 52.60 13.04 3.00

How to apply IPO with HDFC SKY?

Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.

1Login to your HDFC SKY Account

2Select Issue

3Enter Number of Lots and your Price.

4Enter UPI ID

5Complete Transaction on Your UPI App

Learn More About IPO

FAQs On Gujarat Kidney & Super Speciality Limited IPO

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy